https://trans-isomer.com/stoma....ch-bacterial-substan
Therefore, we compared the potency of different curative or palliative chemotherapy regimens regarding the success of esophageal and gastric cancer patients in a "real globe" medical setting. TECHNIQUES We identified a cohort of 966 incident esophageal and gastric cancer customers in Stockholm/Gotland County (a low-risk Western population) during 2008-2013. Customers just who got chemotherapy with curative purpose (n = 279) and palliative purpose (n = 182) were analyzed separately. Using Cox proportional